Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

InspireMD, Inc. (II2.F)

2.2000
0.0000
(0.00%)
As of 8:05:14 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Marvin L. Slosman President, CEO & Director 845.48k -- 1964
Mr. Craig Shore CFO, Chief Administrative Officer, Secretary & Treasurer 567.49k -- 1961
Mr. Shane Thomas Gleason Chief Commercial Officer 462.85k -- 1975
Mr. Andrea Tommasoli Chief Operating Officer 314.93k -- 1972
Mr. Amir Kohen Executive VP of Finance & Regional Manager -- -- --
Mr. Pete J. Ligotti Executive VP & GM of North America -- -- --
Dr. Sol J. Barer Ph.D. Special Advisor to the Board 12.2k -- 1947

InspireMD, Inc.

6303 Waterford District Drive
Suite 215
Miami, FL 33126
United States
888 776 6804 https://www.inspiremd.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
85

Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.

Corporate Governance

InspireMD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 9, 2025 at 12:30 PM UTC

InspireMD, Inc. Earnings Date

Recent Events

Related Tickers